ABC Transporters: From Targets to Antitargets and Back

Ecker, Gerhard

doi:10.1002/9783527679430.ch5

Methods and Principles in Medicinal Chemistry

2017

DOI: 10.1002/9783527679430.ch5

|View full text |Cite

ABC Transporters: From Targets to Antitargets and Back

Gerhard Ecker

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Impact of transporters and enzymes from blood–cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake

Wang

Zuo

2018

Expert Opinion on Drug Metabolism & Toxicology

View full text Add to dashboard Cite

In parallel with the blood-brain barrier (BBB), transporters and enzymes on the blood-cerebrospinal fluid barrier (BCSFB) serve as the first barrier for drug brain uptake. In addition, their expressions on brain parenchyma are considered as the secondary barrier for central nervous system (CNS) drug delivery. Currently, a lack of information on transporters and enzymes expressed on both BCSFB and brain parenchyma is the major cause of failure in CNS drug development. Areas covered: Transporters and enzymes expressed on BCSFB and brain parenchyma and their impact on drug brain uptake were highlighted and compared with that on BBB. Expert opinion: Based on the nature of transporters expressed on BCSFB and the brain parenchyma, the design of CNS therapeutics with chemical structures similar to the substrates of nutrients and hormones transporters could facilitate their CSF and brain parenchyma uptake . Moreover, drugs in systemic circulation could undergo further metabolism at BCSFB and brain parenchyma leading to failure in CNS drug delivery. Impact of the altered expressions and functions of transporters and enzymes on BCSFB and brain parenchyma in different species or disease conditions on CNS drug brain uptake shall be further evaluated using relevant in vitro cell models and pharmacokinetics modeling.

show abstract

Impact of transporters and enzymes from blood–cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake

Wang

Zuo

2018

Expert Opinion on Drug Metabolism & Toxicology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

ABC Transporters: From Targets to Antitargets and Back

Cited by 1 publication

References 55 publications

Impact of transporters and enzymes from blood–cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake

Impact of transporters and enzymes from blood–cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake

Contact Info

Product

Resources

About